Otolaryngology Doctors in Hazleton, PA Accepting Medicare

2 Otolaryngology doctors found. Showing 1 - 2

Jang Jang, Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 108 Ferrara Ave, Hazleton, PA 18201 Phone: 570-459-5502    Fax: 570-459-5502

George J Racho, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 154 N Church St, Hazleton, PA 18201 Phone: 570-454-7188

News Archive

FAM hosts 13th annual event at Webber Cancer Center to benefit patients with fibromyalgia

The Fibromyalgia Association of Michigan (FAM) will host its 13th annual event at the Webber Cancer Center at St. John Macomb-Oakland Hospital on 11800 12 Mile Road from 12:30 - 5:30 PM.

Merus and Selexis receive a € 2.1 million grant for single cell line manufacturing of a bispecific antibody combination to treat colorectal cancer

Merus and Selexis will combine their unique and proprietary Oligoclonics® and SUREtechnology™ platforms respectively to develop a product combining two bispecific full length IgG antibodies that simultaneously targets and potently inhibits three receptor tyrosine kinases...

African-Americans and Asians more pessimistic about the health systems ability to cope with a bioterrorist event

While nearly three-quarters of Americans believe that the public health system would respond fairly in a bioterrorist event, African-Americans and Asians adhere to this view in smaller proportions, perhaps because of past discriminatory policies put in place by health officials, according to a new UCLA study.

Recent releases in global health

In light of a recent Guttmacher Institute report that indicated 70,000 women in developing countries die each year from unsafe abortion, a Lancet editorial outlines ways to reduce deaths, and says, "The current political climate is favourable, because the global-gag rule (the U.S. Government's policy on banning funding of foreign organisations linked to any type of abortion practice) is out of favour" (10/17).

SAFLUTAN launched in United Kingdom and Spain

Merck Sharp & Dohme (MSD) has launched SAFLUTAN (tafluprost) in the United Kingdom and Spain, and additional launches in other countries are expected over the next several months, pending regulatory approvals, the Company said today.

Read more Medical News

› Verified 4 days ago